Li‐Ying Lin
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
Papers in
-
- RNA and protein synthesis mechanisms 3
- Ubiquitin and proteasome pathways 2
- Cancer-related gene regulation 2
- Surgery 8
- Stoma care and complications 4
- Co-authors
- Nei‐Li Chan (4 shared papers)Te‐Sheng Lin (2 shared papers)Yu‐Jen Yu (2 shared papers)Tsai‐Kun Li (1 shared paper)Chyuan-Chuan Wu (1 shared paper)Lynn Farh (1 shared paper)Tien-Jui Yen (1 shared paper)Ruey‐Hsia Wang (5 shared papers)
- Journals
- PLoS ONE (2 papers)Proceedings of the National Academy of Sciences (2 papers)European Journal of Oncology Nursing (2 papers)BMC Cancer (2 papers)Journal of Advanced Nursing (1 paper)
- Partner nations
- ChinaTaiwanUnited Kingdom
In The Last Decade
Li‐Ying Lin
45 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 126
- Toxicology 92
- Molecular Biology 703
- Oncology 219
- Biochemistry 52
- Cancer Research 95
Countries citing papers authored by Li‐Ying Lin
This map shows the geographic impact of Li‐Ying Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Ying Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Ying Lin more than expected).
Fields of papers citing papers by Li‐Ying Lin
This network shows the impact of papers produced by Li‐Ying Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Ying Lin. The network helps show where Li‐Ying Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Li‐Ying Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 437 | |
| 2 | 2015 | 68 | |
| 3 | 2005 | 64 | |
| 4 | 2015 | 61 | |
| 5 | 2012 | 58 | |
| 6 | 2022 | 58 | |
| 7 | 2010 | 37 | |
| 8 | 2018 | 35 | |
| 9 | 2019 | 33 | |
| 10 | 2019 | 30 | |
| 11 | 2017 | 29 | |
| 12 | 2022 | 29 | |
| 13 | 2016 | 20 | |
| 14 | 2012 | 19 | |
| 15 | 2017 | 15 | |
| 16 | 2020 | 15 | |
| 17 | 2019 | 15 | |
| 18 | 2024 | 15 | |
| 19 | 2004 | 14 | |
| 20 | 2020 | 13 |
About Li‐Ying Lin
Li‐Ying Lin is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Infectious Diseases, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include Stoma care and complications (4 papers), Cancer-related molecular mechanisms research (3 papers), Diabetes Management and Education (3 papers), RNA and protein synthesis mechanisms (3 papers), Ubiquitin and proteasome pathways (2 papers), interferon and immune responses (2 papers), Music Therapy and Health (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Toxicology (92 citations), Molecular Biology (703 citations), Oncology (219 citations), Biochemistry (52 citations) and Cancer Research (95 citations). Li‐Ying Lin has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Nei‐Li Chan, Te‐Sheng Lin, Yu‐Jen Yu, Tsai‐Kun Li, Chyuan-Chuan Wu, Lynn Farh, Tien-Jui Yen, Ruey‐Hsia Wang, Chih‐Chiang Chang and Chieh‐Chen Huang. Their work appears in journals such as PLoS ONE, Proceedings of the National Academy of Sciences, European Journal of Oncology Nursing, BMC Cancer and Journal of Advanced Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.